Healthy volunteers test new pill forms for future sickle cell treatment
NCT ID NCT06291285
First seen Jan 10, 2026 · Last updated May 10, 2026 · Updated 17 times
Summary
This study tested two different versions (a tablet and a capsule) of an experimental medicine called NDec in 44 healthy adults. The medicine is being developed for sickle cell disease, but this study only measured how the body absorbs each form. Participants received both versions at different times to compare drug levels in the blood. There was no treatment or health benefit for volunteers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ICON-Salt Lake City
Salt Lake City, Utah, 84124, United States
-
Profil Institut für Stoffwechselforschung GmbH
Neuss, 41460, Germany
Conditions
Explore the condition pages connected to this study.